A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved..
OBJECTIVE: To develop a score to predict mortality in patients with bloodstream infections (BSIs) due to carbapenemase-producing Enterobacteriaceae (CPE).
PATIENTS AND METHODS: A multinational retrospective cohort study (INCREMENT project) was performed from January 1, 2004, through December 31, 2013. Patients with clinically relevant monomicrobial BSIs due to CPE were included and randomly assigned to either a derivation cohort (DC) or a validation cohort (VC). The variables were assessed on the day the susceptibility results were available, and the predictive score was developed using hierarchical logistic regression. The main outcome variable was 14-day all-cause mortality. The predictive ability of the model and scores were measured by calculating the area under the receiver operating characteristic curve. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for different cutoffs of the score.
RESULTS: The DC and VC included 314 and 154 patients, respectively. The final logistic regression model of the DC included the following variables: severe sepsis or shock at presentation (5 points); Pitt score of 6 or more (4 points); Charlson comorbidity index of 2 or more (3 points); source of BSI other than urinary or biliary tract (3 points); inappropriate empirical therapy and inappropriate early targeted therapy (2 points). The score exhibited an area under the receiver operating characteristic curve of 0.80 (95% CI, 0.74-0.85) in the DC and 0.80 (95% CI, 0.73-0.88) in the VC. The results for 30-day all-cause mortality were similar.
CONCLUSION: A validated score predictive of early mortality in patients with BSIs due to CPE was developed.
TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01 764490.
| Errataetall: |
ErratumIn: Mayo Clin Proc. 2016 Dec;91(12 ):1843. - PMID 27916160 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:91 |
|---|---|
| Enthalten in: |
Mayo Clinic proceedings - 91(2016), 10 vom: 14. Okt., Seite 1362-1371 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gutiérrez-Gutiérrez, Belén [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 25.05.2017 Date Revised 17.03.2022 published: Print ErratumIn: Mayo Clin Proc. 2016 Dec;91(12 ):1843. - PMID 27916160 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mayocp.2016.06.024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM265070910 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM265070910 | ||
| 003 | DE-627 | ||
| 005 | 20231224211458.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mayocp.2016.06.024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0883.xml |
| 035 | |a (DE-627)NLM265070910 | ||
| 035 | |a (NLM)27712635 | ||
| 035 | |a (PII)S0025-6196(16)30366-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gutiérrez-Gutiérrez, Belén |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.05.2017 | ||
| 500 | |a Date Revised 17.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: Mayo Clin Proc. 2016 Dec;91(12 ):1843. - PMID 27916160 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVE: To develop a score to predict mortality in patients with bloodstream infections (BSIs) due to carbapenemase-producing Enterobacteriaceae (CPE) | ||
| 520 | |a PATIENTS AND METHODS: A multinational retrospective cohort study (INCREMENT project) was performed from January 1, 2004, through December 31, 2013. Patients with clinically relevant monomicrobial BSIs due to CPE were included and randomly assigned to either a derivation cohort (DC) or a validation cohort (VC). The variables were assessed on the day the susceptibility results were available, and the predictive score was developed using hierarchical logistic regression. The main outcome variable was 14-day all-cause mortality. The predictive ability of the model and scores were measured by calculating the area under the receiver operating characteristic curve. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated for different cutoffs of the score | ||
| 520 | |a RESULTS: The DC and VC included 314 and 154 patients, respectively. The final logistic regression model of the DC included the following variables: severe sepsis or shock at presentation (5 points); Pitt score of 6 or more (4 points); Charlson comorbidity index of 2 or more (3 points); source of BSI other than urinary or biliary tract (3 points); inappropriate empirical therapy and inappropriate early targeted therapy (2 points). The score exhibited an area under the receiver operating characteristic curve of 0.80 (95% CI, 0.74-0.85) in the DC and 0.80 (95% CI, 0.73-0.88) in the VC. The results for 30-day all-cause mortality were similar | ||
| 520 | |a CONCLUSION: A validated score predictive of early mortality in patients with BSIs due to CPE was developed | ||
| 520 | |a TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01 764490 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Validation Study | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Bacterial Proteins |2 NLM | |
| 650 | 7 | |a beta-Lactamases |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 650 | 7 | |a carbapenemase |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 700 | 1 | |a Salamanca, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a de Cueto, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Hsueh, Po-Ren |e verfasserin |4 aut | |
| 700 | 1 | |a Viale, Pierluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Paño-Pardo, José Ramón |e verfasserin |4 aut | |
| 700 | 1 | |a Venditti, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Tumbarello, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Daikos, George |e verfasserin |4 aut | |
| 700 | 1 | |a Pintado, Vicente |e verfasserin |4 aut | |
| 700 | 1 | |a Doi, Yohei |e verfasserin |4 aut | |
| 700 | 1 | |a Tuon, Felipe Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Karaiskos, Ilias |e verfasserin |4 aut | |
| 700 | 1 | |a Machuca, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Schwaber, Mitchell J |e verfasserin |4 aut | |
| 700 | 1 | |a Azap, Özlem Kurt |e verfasserin |4 aut | |
| 700 | 1 | |a Souli, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Roilides, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Pournaras, Spyros |e verfasserin |4 aut | |
| 700 | 1 | |a Akova, Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Bermejo, Joaquín |e verfasserin |4 aut | |
| 700 | 1 | |a Oliver, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Almela, Manel |e verfasserin |4 aut | |
| 700 | 1 | |a Lowman, Warren |e verfasserin |4 aut | |
| 700 | 1 | |a Almirante, Benito |e verfasserin |4 aut | |
| 700 | 1 | |a Bonomo, Robert A |e verfasserin |4 aut | |
| 700 | 1 | |a Carmeli, Yehuda |e verfasserin |4 aut | |
| 700 | 1 | |a Paterson, David L |e verfasserin |4 aut | |
| 700 | 1 | |a Pascual, Alvaro |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Baño, Jesús |e verfasserin |4 aut | |
| 700 | 0 | |a Investigators from the REIPI/ESGBIS/INCREMENT Group |e verfasserin |4 aut | |
| 700 | 1 | |a Gálvez, J |e investigator |4 oth | |
| 700 | 1 | |a Falcone, M |e investigator |4 oth | |
| 700 | 1 | |a Russo, A |e investigator |4 oth | |
| 700 | 1 | |a Giamarellou, H |e investigator |4 oth | |
| 700 | 1 | |a Trecarichi, E M |e investigator |4 oth | |
| 700 | 1 | |a Losito, A R |e investigator |4 oth | |
| 700 | 1 | |a García-Vázquez, E |e investigator |4 oth | |
| 700 | 1 | |a Hernández, A |e investigator |4 oth | |
| 700 | 1 | |a Gómez, J |e investigator |4 oth | |
| 700 | 1 | |a Iosifidis, E |e investigator |4 oth | |
| 700 | 1 | |a Prim, N |e investigator |4 oth | |
| 700 | 1 | |a Navarro, F |e investigator |4 oth | |
| 700 | 1 | |a Mirelis, B |e investigator |4 oth | |
| 700 | 1 | |a Origüen, J |e investigator |4 oth | |
| 700 | 1 | |a San Juan, R |e investigator |4 oth | |
| 700 | 1 | |a Fernández-Ruiz, M |e investigator |4 oth | |
| 700 | 1 | |a Larrosa, N |e investigator |4 oth | |
| 700 | 1 | |a Puig-Asensio, M |e investigator |4 oth | |
| 700 | 1 | |a Cisneros, J M |e investigator |4 oth | |
| 700 | 1 | |a Molina, J |e investigator |4 oth | |
| 700 | 1 | |a González, V |e investigator |4 oth | |
| 700 | 1 | |a Rucci, V |e investigator |4 oth | |
| 700 | 1 | |a Ruiz de Gopegui, E |e investigator |4 oth | |
| 700 | 1 | |a Marinescu, C I |e investigator |4 oth | |
| 700 | 1 | |a Martínez-Martínez, L |e investigator |4 oth | |
| 700 | 1 | |a Fariñas, M C |e investigator |4 oth | |
| 700 | 1 | |a Cano, M E |e investigator |4 oth | |
| 700 | 1 | |a Gozalo, M |e investigator |4 oth | |
| 700 | 1 | |a Mora-Rillo, M |e investigator |4 oth | |
| 700 | 1 | |a Navarro-San Francisco, C |e investigator |4 oth | |
| 700 | 1 | |a Peña, C |e investigator |4 oth | |
| 700 | 1 | |a Gómez-Zorrilla, S |e investigator |4 oth | |
| 700 | 1 | |a Tubau, F |e investigator |4 oth | |
| 700 | 1 | |a Tsakris, A |e investigator |4 oth | |
| 700 | 1 | |a Zarkotou, O |e investigator |4 oth | |
| 700 | 1 | |a Azap, Ö K |e investigator |4 oth | |
| 700 | 1 | |a Pitout, J |e investigator |4 oth | |
| 700 | 1 | |a Virmani, D |e investigator |4 oth | |
| 700 | 1 | |a Torre-Cisneros, J |e investigator |4 oth | |
| 700 | 1 | |a Natera, C |e investigator |4 oth | |
| 700 | 1 | |a Helvaci, Ö |e investigator |4 oth | |
| 700 | 1 | |a Sahin, A O |e investigator |4 oth | |
| 700 | 1 | |a Cantón, R |e investigator |4 oth | |
| 700 | 1 | |a Ruiz, P |e investigator |4 oth | |
| 700 | 1 | |a Bartoletti, M |e investigator |4 oth | |
| 700 | 1 | |a Giannella, M |e investigator |4 oth | |
| 700 | 1 | |a Tacconelli, E |e investigator |4 oth | |
| 700 | 1 | |a Riemenschneider, F |e investigator |4 oth | |
| 700 | 1 | |a Calbo, E |e investigator |4 oth | |
| 700 | 1 | |a Badia, C |e investigator |4 oth | |
| 700 | 1 | |a Xercavins, M |e investigator |4 oth | |
| 700 | 1 | |a Gasch, E |e investigator |4 oth | |
| 700 | 1 | |a Fontanals, D |e investigator |4 oth | |
| 700 | 1 | |a Jové, E |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Mayo Clinic proceedings |d 1964 |g 91(2016), 10 vom: 14. Okt., Seite 1362-1371 |w (DE-627)NLM000074527 |x 1942-5546 |7 nnns |
| 773 | 1 | 8 | |g volume:91 |g year:2016 |g number:10 |g day:14 |g month:10 |g pages:1362-1371 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mayocp.2016.06.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 91 |j 2016 |e 10 |b 14 |c 10 |h 1362-1371 | ||